Drug Shortage Report for OPTIRAY 320
| Report ID | 170411 |
| Drug Identification Number | 01900854 |
| Brand name | OPTIRAY 320 |
| Common or Proper name | Ioversol Injection 68% |
| Company Name | LIEBEL-FLARSHEIM COMPANY LLC |
| Market Status | MARKETED |
| Active Ingredient(s) | IOVERSOL |
| Strength(s) | 68% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVASCULAR INTRAVASCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 50 mL |
| ATC code | V08AB |
| ATC description | X-RAY CONTRAST MEDIA, IODINATED |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2022-07-15 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-04-30 |
| Company comments | Estimated end date remains unknown, awaiting supply from manufacturer. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8800 DURANT RD. RALEIGH, NORTH CAROLINA UNITED STATES 27616 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-04-30 | French | Compare |
| v5 | 2025-04-30 | English | Compare |
| v4 | 2023-01-04 | French | Compare |
| v3 | 2023-01-04 | English | Compare |
| v2 | 2022-09-28 | French | Compare |
| v1 | 2022-09-28 | English | Compare |
Showing 1 to 6 of 6